Author

Christopher John Hawkey 1

1 University of Nottingham Nottingham Digest. Disease Centre Queen's Medical Centre

A RANDOMISED CONTROLLED CLINICAL TRIAL OF AUTOLOGOUS STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH TREATMENT REFRACTORY CROHN’S DISEASE (LOW INTENSITY THERAPY EVALUATION): ASTICLITE

James Lindsay, Alan J Lobo, John Snowden, Hannah Berntsson, Mike Bradburn, Lauren Desoysa, Shahida Din, John Gribben, Danny Hind, Ellen Lee, Yash Mahida, Gordon Moran, Peter Irving, Christopher John Hawkey, Miles Parkes, Lizzie Swaby, Simon Travis, Sree Subramanian, Jack Satsangi

Approach to aspirin, clopidogrel and NSAIDs in acute UGIB

Christopher John Hawkey

Bleeding peptic ulcer in 2017

Christopher John Hawkey

Bleeding peptic ulcer in 2017

Christopher John Hawkey

CLINICAL AND ENDOSCOPIC IMPROVEMENT FOLLOWING HEMOPOIETIC STEM CELL TRANSPLANTATION VS MOBILISATIION ALONE IN CROHN'S DISEASE

Christopher John Hawkey

Clinical approaches to the anaemic patient

Christopher John Hawkey

Clinical approaches to the anaemic patient

Christopher John Hawkey

CLINICAL DISEASE ACTIVITY INFLUENCES THE THERAPEUTIC EFFICACY OF THE TOLL LIKE RECEPTOR-9 AGONIST COBITOLIMOD IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Raja Atreya, Laurent Peyrin-Biroulet, Walter Reinisch, Franco Scaldaferri, Charlotte Admyre, Thomas Knittel, Jan Kowalski, Markus F. Neurath, Christopher John Hawkey

CLINICAL EFFICACY OF THE TOLL LIKE RECEPTOR-9 AGONIST COBITOLIMOD IN ANTI-TNF-ANTIBODY TREATED AND NAIVE PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Raja Atreya, Walter Reinisch, Laurent Peyrin-Biroulet, Franco Scaldaferri, Charlotte Admyre, Thomas Knittel, Jan Kowalski, Christopher John Hawkey

New oral anticoagulants (NOACs) and GI

Christopher John Hawkey

Item 1 - 10 / 33
1
2 3 4